These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15579437)

  • 1. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
    Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
    Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
    Tait LR; Pauley RJ; Santner SJ; Heppner GH; Heng HH; Rak JW; Miller FR
    Int J Cancer; 2007 May; 120(10):2127-34. PubMed ID: 17266026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
    Hong Y; Limback D; Elsarraj HS; Harper H; Haines H; Hansford H; Ricci M; Kaufman C; Wedlock E; Xu M; Zhang J; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Aripoli A; Huppe A; Balanoff C; Wagner JL; Amin AL; Larson KE; Ricci L; Tawfik O; Razek H; Meierotto RO; Madan R; Godwin AK; Thompson J; Hilsenbeck SG; Futreal A; Thompson A; Hwang ES; Fan F; Behbod F;
    J Pathol; 2022 Feb; 256(2):186-201. PubMed ID: 34714554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
    Potter SM; Dwyer RM; Hartmann MC; Khan S; Boyle MP; Curran CE; Kerin MJ
    Breast Cancer Res Treat; 2012 Jan; 131(2):401-11. PubMed ID: 21344235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP; Werdell J; Tait L
    Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer.
    Nangia-Makker P; Wang Y; Raz T; Tait L; Balan V; Hogan V; Raz A
    Int J Cancer; 2010 Dec; 127(11):2530-41. PubMed ID: 20162566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
    Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
    J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
    Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
    Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
    Chang H; Mohabir N; Done S; Hamel PA
    J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
    Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.
    Smith L; Baxter EW; Chambers PA; Green CA; Hanby AM; Hughes TA; Nash CE; Millican-Slater RA; Stead LF; Verghese ET; Speirs V
    PLoS One; 2015; 10(10):e0139698. PubMed ID: 26437339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.